向特定对象发行股票

Search documents
泰胜风能: 华泰联合证券有限责任公司、粤开证券股份有限公司关于泰胜风能集团股份有限公司2024年度向特定对象发行股票并在创业板上市之发行保荐书
Zheng Quan Zhi Xing· 2025-09-02 10:24
Group 1 - The issuer, Taisheng Wind Power Group Co., Ltd., is applying for a specific object stock issuance and listing on the ChiNext board, with Huatai United Securities as the sponsor [1][3] - The total share capital of the issuer as of June 30, 2025, is 934,899,232 shares, with 30.85% being restricted shares and 69.15% being unrestricted shares [7] - The top ten shareholders hold a total of 369,298,730 shares, accounting for 39.49% of the total share capital [7] Group 2 - The issuer's business includes sales of metal structures, onshore and offshore wind turbine sales, and manufacturing of marine engineering equipment [7] - As of June 30, 2025, the issuer's total assets amount to 1,015,133.58 million, with total liabilities of 559,493.05 million and shareholders' equity of 455,640.52 million [11] - The issuer's revenue for the first half of 2025 is reported at 229,854.49 million, with a net profit of 11,506.27 million [11] Group 3 - The fundraising amount for the stock issuance is expected to be no more than 117,592.92 million, which will be used to supplement working capital [25][26] - The issuance price is set at 6.76 per share, which complies with the regulations of not being lower than 80% of the average stock price over the previous 20 trading days [27][28] - The issuer has completed the necessary internal decision-making procedures for the stock issuance, including board and shareholder meetings [17][18]
永辉超市: 永辉超市股份有限公司关于调整公司2025年度向特定对象发行A股股票方案的公告
Zheng Quan Zhi Xing· 2025-09-01 16:27
Group 1 - The company has adjusted the scale of funds to be raised in the A-share issuance plan for 2025, reducing the number of stores to be renovated from 298 to 216, with the remaining renovations funded by its own capital [1][2] - The total amount of funds to be raised in the issuance has been revised to not exceed 311,386.04 million yuan, down from the previous 399,207.99 million yuan [2][3] - The total investment for the projects funded by the raised capital is now 468,829.86 million yuan, with the net amount after deducting issuance costs allocated accordingly [2][3] Group 2 - The company retains the right to use its own or self-raised funds for the investment projects before the raised funds are in place, with a plan to replace these funds once the raised capital is available [2][3] - Other parts of the A-share issuance plan remain unchanged despite the adjustments made [3]
白云机场: 立信会计师事务所(特殊普通合伙)关于广州白云国际机场股份有限公司向特定对象发行股票申请文件的审核问询函的回复(2025年半年报财务数据更新版)
Zheng Quan Zhi Xing· 2025-09-01 16:18
Core Viewpoint - The company is seeking to raise up to 1.6 billion yuan through a private placement to enhance liquidity and support ongoing operational and capital expenditure needs, as well as to optimize its capital structure and improve its debt repayment capacity [1][3][11]. Financing Scale - The total amount expected to be raised from the issuance is not more than 1.6 billion yuan, which will be used entirely to supplement working capital after deducting issuance costs [1][3]. - As of June 30, 2025, the company had a cash balance of approximately 573 million yuan, with a liquidity ratio of 1.16 and a quick ratio of 1.14, indicating slight liquidity pressure compared to other A-share listed airport companies [1][3]. Financial Needs Assessment - The company estimates a total funding gap of approximately 2.017 billion yuan over the next three years, considering existing cash reserves, future cash inflows, and capital expenditures [2][3][11]. - The projected cash flow from operations over the next three years is estimated at approximately 710 million yuan, with a significant portion of future cash needs driven by capital expenditures and rental payments [3][5][11]. Business and Operational Performance - The company reported fluctuating revenues over the past few years, with significant recovery in 2023 and continued growth expected in 2024 and 2025, driven by increased passenger throughput and operational efficiency [8][14]. - The revenue for 2023 was approximately 643 million yuan, with a net profit of about 38 million yuan, indicating a recovery from previous losses [8][14]. Industry Context - The aviation industry is experiencing a strong recovery, with the International Air Transport Association (IATA) projecting a 5.1% annual growth rate in passenger traffic in the Asia-Pacific region over the next 20 years [3][14]. - The company’s operational metrics, such as passenger throughput and flight operations, are closely aligned with industry trends, reflecting a robust recovery in demand for air travel [14].
白云机场: 广州白云国际机场股份有限公司关于向特定对象发行股票募集说明书等申请文件更新的提示性公告
Zheng Quan Zhi Xing· 2025-09-01 16:18
证券代码:600004 证券简称:白云机场 公告编号:2025-040 募集说明书及相关申请文件所述事项并不代表发行审核、注册部 门对于公司本次向特定对象发行 A 股股票相关事项的实质性判断、 确认、批准或核准,相关披露文件所述本次发行相关事项的生效及完 成尚需上海证券交易所审核通过及中国证券监督管理委员会同意注 册后方可实施,敬请广大投资者注意投资风险。 特此公告。 广州白云国际机场股份有限公司董事会 广州白云国际机场股份有限公司 关于向特定对象发行股票募集说明书等申请文件 更新的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 鉴于广州白云国际机场股份有限公司(以下简称"公司")已于 半年度报告》,公司会同相关中介机构对募集说明书、审核问询函回 复等申请文件中涉及的财务数据及其他事项进行了更新。具体内容详 见公司于 2025 年 9 月 2 日在上海证券交易所网站披露的《广州白云 国际机场股份有限公司 2024 年度向特定对象发行 A 股股票募集说明 书(2025 年半年报财务数据更新版)》《关于广州白云国际机场 ...
永辉超市: 永辉超市股份有限公司监事会关于调整公司2025年度向特定对象发行A股股票相关事项的书面审核意见
Zheng Quan Zhi Xing· 2025-09-01 16:18
关于调整公司 2025 年度向特定对象发行股票事项的书面审核意见 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民 共和国证券法》(以下简称"《证券法》")以及《上市公司证券发行注册管理 办法》(以下简称"《管理办法》")等相关法律、法规及规范性文件的有关规 定,监事会在全面了解和审核公司调整后的 2025 年度向特定对象发行 A 股股票 (以下简称"本次发行")的相关文件后,发表书面审核意见如下: 范性文件的相关规定,符合公司和全体股东的利益。 票预案(修订稿)》《永辉超市股份有限公司 2025 年度向特定对象发 行 A 股股票募集资金使用可行性分析报告(修订稿)》《永辉超市股份 有限公司 2025 年度向特定对象发行 A 股股票方案论证分析报告(修订 稿)》等相关文件所披露的信息真实、准确、完整,不存在任何虚假记 载、误导性陈述或者重大遗漏。 本实力,优化资产结构,增强偿债能力,改善现金流状况,进一步提升 公司的竞争优势,符合公司长远发展目标和股东利益。 永辉超市股份有限公司监事会关于调整公司 2025 年度向特定对象发行股票事项的书面审核意见 永辉超市股份有限公司监事会 《关于首发及再 ...
永辉超市: 永辉超市股份有限公司关于2025年度向特定对象发行A股股票预案及相关文件修订情况说明的公告
Zheng Quan Zhi Xing· 2025-09-01 16:18
Core Viewpoint - Yonghui Supermarket Co., Ltd. has revised its plan for the issuance of A-shares to specific investors for the year 2025, adjusting the fundraising scale and the number of stores to be renovated [1][2][3] Summary by Sections Section 1: Revision of A-Share Issuance Plan - The total amount of funds raised through the issuance of A-shares has been modified from CNY 399,207.99 million to a new limit [1][2] - The total investment for the store renovation project has been reduced from CNY 559,707.27 million to CNY 397,929.14 million [1][2] - The amount allocated for "supplementing working capital or repaying bank loans" has been adjusted from CNY 47,000.00 million to CNY 40,000.00 million [1][3] - The number of stores planned for renovation has been decreased from 298 to 216 [1][3] Section 2: Feasibility Analysis of Fund Usage - The feasibility analysis report for the use of funds raised through the A-share issuance has been updated to reflect the changes in the number of stores [2][3] Section 3: Issuance Scheme Justification Report - The issuance scheme justification report has been revised based on the adjusted fundraising scale and the financial data from the 2025 semi-annual report [2][3] Section 4: Dilution of Immediate Returns - The company has revised the content related to the dilution of immediate returns and measures to compensate for this dilution, in light of the adjustments made to the fundraising scale and the latest financial data [2][3]
欧林生物: 成都欧林生物科技股份有限公司第七届董事会独立董事专门会议2025年第二次会议决议
Zheng Quan Zhi Xing· 2025-08-31 10:13
Group 1 - The independent board meeting of Chengdu Olin Biotechnology Co., Ltd. was held on August 29, 2025, with all three independent directors present, confirming the legality and validity of the meeting [1][2] - The meeting unanimously approved the proposal to terminate the simplified procedure for issuing A-shares to specific targets and to withdraw the application documents, indicating a prudent decision based on the company's actual situation [1] - The independent directors concluded that this decision would not adversely affect the company's production, operations, or business development, nor would it harm the interests of the company and all shareholders [1]
欧林生物终止向特定对象发行股票事项
Zhi Tong Cai Jing· 2025-08-31 07:56
Core Viewpoint - The company has decided to terminate the issuance of shares to specific targets through a simplified procedure due to current market conditions and its own development plans [1] Group 1 - The company's board, management, and intermediaries have been actively working on the share issuance since the initial announcement [1] - The decision to terminate the share issuance will not adversely affect the company's normal production and operations [1] - The "Vaccine R&D Production Base Technical Transformation Project" is progressing as planned [1]
创世纪更新向特定对象发行股票申请文件,审核结果仍存不确定性
Xin Lang Cai Jing· 2025-08-29 18:36
登录新浪财经APP 搜索【信披】查看更多考评等级 market 广东创世纪智能装备集团股份有限公司于2025年8月30日发布关于申请向特定对象发行股票的审 核问询函回复(豁免版)(修订稿)及募集说明书等申请文件更新的提示性公告。 2025年7月8日,创世纪收到深圳证券交易所出具的《关于广东创世纪智能装备集团股份有限公司申请向 特定对象发行股票的审核问询函》。公司收到问询函后,会同相关中介机构对问题进行认真研究落实, 于7月29日在巨潮资讯网披露了回复及申请文件补充更新内容。 近日,公司根据深交所进一步审核意见,再次会同中介机构对问询函所列问题、募集说明书等申请文件 进行相应补充、更新和修订,相关文件于同日在巨潮资讯网披露。 值得注意的是,创世纪本次向特定对象发行股票事项尚需通过深交所审核,并获得中国证监会同意注册 后方可实施。最终能否通过深交所审核并获得中国证监会同意注册的决定及其时间都存在不确定性。公 司表示将根据事项进展及时履行信息披露义务,提醒广大投资者谨慎决策,注意投资风险。 点击查看公告原文>> 声明:市场有风险,投资需谨慎。 本文为AI大模型基于第三方数据库自动发布,任何在本文出现的信 息(包括但 ...
南方精工: 半年报董事会决议公告
Zheng Quan Zhi Xing· 2025-08-29 17:47
Board Meeting Summary - The board meeting was convened via email notification to all directors, adhering to legal and regulatory requirements [2] - The board unanimously approved the 2025 semi-annual report, confirming its compliance with relevant laws and regulations, and ensuring the report accurately reflects the company's operational and financial status [2][3] Auditor Change - The company decided not to renew the contract with Tianheng Accounting Firm and plans to appoint Tianjian Accounting Firm as the new auditor, with unanimous approval from the board [3][4] Fundraising Plan Adjustment - The company adjusted its fundraising plan for a specific stock issuance, with a total fundraising amount not exceeding 187.53 million yuan, which is capped at 30% of the total share capital prior to the issuance [3][4] - The adjustment was made due to the company's financial investments exceeding 10% of the net assets, leading to a reduction in the fundraising amount by 176.54 million yuan [5][6] Fund Utilization - The net proceeds from the fundraising will be allocated to specific projects, and if the actual funds raised are less than the total required, the board will prioritize the projects based on actual funding needs [6][7] Future Meetings - The company plans to hold its second extraordinary general meeting on September 16, 2025, with unanimous approval from the board [9]